Leptin constrains phospholipase C-protein kinase C-induced insulin secretion via a phosphatidylinositol 3-kinase-dependent pathway

Exp Biol Med (Maywood). 2003 Feb;228(2):175-82. doi: 10.1177/153537020322800207.

Abstract

Leptin-deficient Lep(ob)/Lep(ob)mice hypersecrete insulin in response to acetylcholine stimulation of the phospholipase C-protein kinase C (PLC-PKC) pathway, and leptin constrains this hypersecretion. Leptin has been reported to activate phosphatidylinositol 3-kinase (PI 3-K) and subsequently phosphodiesterase (PDE) to impair protein kinase A (PKA)-induced insulin secretion from cultured islets of neonatal rats. We determined if PKA-induced insulin secretion was also hyperresponsive in islets from Lep(ob)/Lep(ob)mice, and if leptin impaired this pathway in islets from these mice. Additionally, the possible role for PI 3-K and PDE in leptin-induced control of acetylcholine-induced insulin secretion was examined. Stimulation of insulin secretion with GLP-1, forskolin (an activator of adenylyl cyclase), or IBMX (an inhibitor of PDE) did not cause hypersecretion of insulin from islets of young Lep(ob)/Lep(ob)mice, and leptin did not inhibit GLP-1-induced insulin secretion from islets of these mice. Inhibition of PDE with IBMX also did not block leptin-induced inhibition of acetylcholine-mediated insulin secretion from islets of Lep(ob)/Lep(ob)mice. But, preincubation of islets with wortmannin, an inhibitor of PI 3-K activity, blocked the ability of leptin to constrain acetylcholine-induced insulin secretion from islets of Lep(ob)/Lep(ob)mice. We conclude that the capacity of the PKA pathway to stimulate insulin secretion is not increased in islets from young Lep(ob)/Lep(ob)mice, and that leptin does not regulate this pathway in islets from mice. Leptin may stimulate PI 3-K to constrain PLC-PKC-induced insulin secretion from islets of Lep(ob)/Lep(ob)mice.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 1-Methyl-3-isobutylxanthine / pharmacology
  • Acetylcholine / pharmacology
  • Androstadienes / pharmacology
  • Animals
  • Cells, Cultured
  • Colforsin / pharmacology
  • Cyclic AMP-Dependent Protein Kinases / metabolism
  • Glucagon / pharmacology
  • Glucagon-Like Peptide 1
  • Insulin / metabolism*
  • Insulin Secretion
  • Islets of Langerhans / cytology
  • Islets of Langerhans / drug effects
  • Islets of Langerhans / metabolism
  • Leptin / genetics
  • Leptin / metabolism*
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Peptide Fragments / pharmacology
  • Phosphatidylinositol 3-Kinases / metabolism*
  • Phosphodiesterase Inhibitors / pharmacology
  • Phosphoinositide-3 Kinase Inhibitors
  • Protein Kinase C / metabolism*
  • Protein Precursors / pharmacology
  • Signal Transduction / physiology
  • Type C Phospholipases / metabolism*
  • Wortmannin

Substances

  • Androstadienes
  • Insulin
  • Leptin
  • Peptide Fragments
  • Phosphodiesterase Inhibitors
  • Phosphoinositide-3 Kinase Inhibitors
  • Protein Precursors
  • Colforsin
  • Glucagon-Like Peptide 1
  • Glucagon
  • Cyclic AMP-Dependent Protein Kinases
  • Protein Kinase C
  • Type C Phospholipases
  • Acetylcholine
  • 1-Methyl-3-isobutylxanthine
  • Wortmannin